- Home
- LUCD vs CRUS Comparison
LUCD vs CRUS Comparison
Compare LUCD & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- CRUS
- Stock Information
- Founded
- LUCD 2018
- CRUS 1984
- Country
- LUCD United States
- CRUS United States
- Employees
- LUCD 70
- CRUS N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRUS Semiconductors
- Sector
- LUCD Health Care
- CRUS Technology
- Exchange
- LUCD Nasdaq
- CRUS Nasdaq
- Market Cap
- LUCD 135.6M
- CRUS N/A
- IPO Year
- LUCD 2021
- CRUS 1989
- Fundamental
- Price
- LUCD $1.16
- CRUS $100.49
- Analyst Decision
- LUCD Strong Buy
- CRUS Strong Buy
- Analyst Count
- LUCD 4
- CRUS 6
- Target Price
- LUCD $3.88
- CRUS $124.50
- AVG Volume (30 Days)
- LUCD 1.3M
- CRUS 632.4K
- Earning Date
- LUCD 05-14-2025
- CRUS 05-06-2025
- Dividend Yield
- LUCD N/A
- CRUS N/A
- EPS Growth
- LUCD N/A
- CRUS 22.45
- EPS
- LUCD N/A
- CRUS 6.00
- Revenue
- LUCD $4,346,000.00
- CRUS $1,896,077,000.00
- Revenue This Year
- LUCD $107.75
- CRUS N/A
- Revenue Next Year
- LUCD $231.37
- CRUS $8.28
- P/E Ratio
- LUCD N/A
- CRUS $16.26
- Revenue Growth
- LUCD 79.00
- CRUS 5.99
- 52 Week Low
- LUCD $0.63
- CRUS $75.83
- 52 Week High
- LUCD $1.80
- CRUS $147.46
- Technical
- Relative Strength Index (RSI)
- LUCD 41.93
- CRUS 60.26
- Support Level
- LUCD $1.19
- CRUS $91.32
- Resistance Level
- LUCD $1.24
- CRUS $99.76
- Average True Range (ATR)
- LUCD 0.07
- CRUS 2.83
- MACD
- LUCD -0.00
- CRUS 1.17
- Stochastic Oscillator
- LUCD 15.79
- CRUS 94.93
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.